There is a lot going on in the Rheumatoid Arthritis (RA) market at the moment with news last week from Pfizer that tofacitinib had met its study endpoints. A number of new products in the pipeline will have an impact on this Pharma market. RA is an autoimmune disease that causes chronic inflammation of the […]
Tag Archives | JAMA
Sally Church on Pharma Strategy Blog discusses two papers and an editorial on Whole Genome Sequencing published in the Journal of the American Medical Association (JAMA) this week. The ability to sequence and screen the entire genetic information of an individual is now within reach. DNA sequencing costs have decreased over a 100-fold over the […]
Sally Church on Pharma Strategy Blog discusses the issue of to what extent hormone replacement therapy (HRT) is linked to a higher incidence of breast cancer?